HopeStage
Back to all studies
Not recruitingISRCTN90916365

Effectiveness of lamotrigine in Borderline personality disorder; Mental and Behavioural Disorders; Emotionally unstable personality disorder

This study is not recruiting in the United Kingdom. It is testing lamotrigine for Borderline personality disorder; Mental and Behavioural Disorders; Emotionally unstable personality disorder.

Personality disorders, Borderline personality, ...OtherOver 18 Years
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Imperial College London (UK)
Sponsor type
University
Study type
Other
Intervention type
Other / unclear
Study phase
Not ApplicableFormal phases are mostly used for medication studies and some device studies. Some studies do not use a phase.
Locations
United Kingdom
Age range
Over 18 Years
Official registry ID
ISRCTN90916365
Official title
The clinical and cost effectiveness of lamotrigine for people with borderline personality disorder: a randomised controlled trial

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: ISRCTN90916365. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Not recruiting

United Kingdom

Compensation and expense reimbursement have not been verified for this summary.

Registry details
Registry conditions (original wording)

Borderline personality disorder; Mental and Behavioural Disorders; Emotionally unstable personality disorder; Borderline Personality Disorder

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Imperial College London (UK), a university.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as not recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me